Details for New Drug Application (NDA): 021530
✉ Email this page to a colleague
The generic ingredient in MELOXICAM is meloxicam. There are twenty-two drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the meloxicam profile page.
Summary for 021530
Tradename: | MELOXICAM |
Applicant: | Avondale Pharms |
Ingredient: | meloxicam |
Patents: | 0 |
Pharmacology for NDA: 021530
Mechanism of Action | Cyclooxygenase Inhibitors |
Suppliers and Packaging for NDA: 021530
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MELOXICAM | meloxicam | SUSPENSION;ORAL | 021530 | NDA | Avondale Pharmaceuticals, LLC | 71740-339 | 71740-339-11 | 1 BOTTLE, PLASTIC in 1 CARTON (71740-339-11) / 100 mL in 1 BOTTLE, PLASTIC |
MELOXICAM | meloxicam | SUSPENSION;ORAL | 021530 | NDA AUTHORIZED GENERIC | Emerald Therapeutics, LLC | 72919-124 | 72919-124-10 | 1 BOTTLE, PLASTIC in 1 CARTON (72919-124-10) / 100 mL in 1 BOTTLE, PLASTIC |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 7.5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jun 1, 2004 | TE: | RLD: | Yes |
Expired US Patents for NDA 021530
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Avondale Pharms | MELOXICAM | meloxicam | SUSPENSION;ORAL | 021530-001 | Jun 1, 2004 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription